DK1615992T3 - Prionproteinbindende materialer og fremgangsmåder til anvendelse - Google Patents

Prionproteinbindende materialer og fremgangsmåder til anvendelse

Info

Publication number
DK1615992T3
DK1615992T3 DK04758843T DK04758843T DK1615992T3 DK 1615992 T3 DK1615992 T3 DK 1615992T3 DK 04758843 T DK04758843 T DK 04758843T DK 04758843 T DK04758843 T DK 04758843T DK 1615992 T3 DK1615992 T3 DK 1615992T3
Authority
DK
Denmark
Prior art keywords
prion protein
binding materials
methods
protein binding
binding
Prior art date
Application number
DK04758843T
Other languages
English (en)
Inventor
Steven J Burton
David J Hammond
Ruben G Carbonell
Honglue Shen
Viterose Wiltshire-Lyerly
Patrick V Gurgel
Original Assignee
Pathogen Removal & Diagnostic Technologies Inc
Univ North Carolina State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pathogen Removal & Diagnostic Technologies Inc, Univ North Carolina State filed Critical Pathogen Removal & Diagnostic Technologies Inc
Application granted granted Critical
Publication of DK1615992T3 publication Critical patent/DK1615992T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04758843T 2003-04-04 2004-04-02 Prionproteinbindende materialer og fremgangsmåder til anvendelse DK1615992T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46047403P 2003-04-04 2003-04-04
PCT/US2004/010315 WO2004090102A2 (en) 2003-04-04 2004-04-02 Prion protein binding materials and methods of use

Publications (1)

Publication Number Publication Date
DK1615992T3 true DK1615992T3 (da) 2013-12-09

Family

ID=33159772

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04758843T DK1615992T3 (da) 2003-04-04 2004-04-02 Prionproteinbindende materialer og fremgangsmåder til anvendelse

Country Status (16)

Country Link
US (1) US7393658B2 (da)
EP (1) EP1615992B1 (da)
JP (1) JP4783727B2 (da)
CN (1) CN1842707B (da)
AU (1) AU2004227389B2 (da)
CA (1) CA2521438C (da)
DK (1) DK1615992T3 (da)
EG (1) EG26681A (da)
ES (1) ES2436638T3 (da)
HK (1) HK1091894A1 (da)
IL (1) IL171279A (da)
NZ (1) NZ543371A (da)
PL (1) PL1615992T3 (da)
PT (1) PT1615992E (da)
SG (1) SG187269A1 (da)
WO (1) WO2004090102A2 (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1953551B1 (en) * 2002-12-03 2014-02-19 Pathogen Removal and Diagnostic Technologies, Inc. Prion protein ligands and methods of use
JP4428616B2 (ja) * 2003-05-06 2010-03-10 オルガノ株式会社 グラフト修飾有機多孔質体及びその製造方法並びに吸着剤、クロマトグラフィー用充填剤及びイオン交換体
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
US7439041B2 (en) 2003-08-13 2008-10-21 Novartis Vaccines And Diagnostics, Inc. Prion-specific peptide reagents
US20050054003A1 (en) * 2003-09-10 2005-03-10 Stenland Christopher J. Prion clearance using particulate metal oxides
AP2006003861A0 (en) * 2004-06-09 2006-12-31 Pathogen Removal And Diagnosti Particles embedded in a porous substrate for removing target analyte from a sample
WO2006076687A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Elisa assays using prion-specific peptide reagents
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
WO2006076497A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Osplation of pathogenic prions
WO2007030804A1 (en) 2005-09-09 2007-03-15 Novartis Ag Prion-specific peptoid reagents
FR2891747B1 (fr) 2005-10-10 2007-12-14 Maco Pharma Sa Unite de filtration pour l'elimination selective d'une substance cible
EP2036584B1 (en) * 2006-06-27 2015-01-21 Asahi Kasei Kabushiki Kaisha Substrate for biological fluid treatment
RU2410128C2 (ru) * 2006-07-12 2011-01-27 Асахи Касеи Медикал Ко., Лтд. Способ удаления патологического прионного белка из продуктов крови
AU2009243060A1 (en) * 2008-04-30 2009-11-05 Novartis Ag. Assay for pathogenic conformers
ME03596B (me) 2009-04-15 2020-07-20 Abraxis Bioscience Llc Kompozicije nanočesтica bez priona i postupci povezani sa njima
PL221899B1 (pl) * 2011-05-06 2016-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Czysta albumina oraz sposób jej otrzymywania i detekcji
FR2983735B1 (fr) * 2011-12-13 2019-12-13 Maco Pharma Nouvelle utilisation d'un materiau capable de lier la proteine prion
CN113376364A (zh) 2015-08-10 2021-09-10 Essenlix 公司 步骤简化、小样品、快速、易使用的生物/化学分析装置和方法
AU2016323062A1 (en) 2015-09-14 2018-04-12 Essenlix Corp. Device and system for analyzing a sample, particularly blood, as well as methods of using the same
AU2016323072B2 (en) 2015-09-14 2019-09-19 Essenlix Corporation Device and system for collecting and analyzing vapor condensate, particularly exhaled breath condensate, as well as method of using the same
JP6667052B1 (ja) 2016-12-21 2020-03-18 エッセンリックス コーポレーション 試料を認証するためのデバイスおよび方法ならびにその使用
EP3579981A4 (en) 2017-02-07 2021-03-31 Essenlix Corporation COMPRESSED OPEN FLOW TEST AND USE
WO2018148470A1 (en) 2017-02-08 2018-08-16 Essenlix Corporation Sample collection and handling for delayed analysis
US11927560B2 (en) 2017-02-08 2024-03-12 Essenlix Corporation Bio/chemical material extraction and assay
EP3580565B1 (en) 2017-02-09 2024-05-29 Essenlix Corporation Assay using different spacing heights
CA3053120A1 (en) 2017-02-09 2018-08-16 Essenlix Corporation Colorimetric assays
US11940382B2 (en) 2017-02-09 2024-03-26 Essenlix Corporation Assay with amplification
US10966634B2 (en) 2017-02-16 2021-04-06 Essenlix Corporation Assay with textured surface
CN111492222A (zh) 2017-08-01 2020-08-04 Essenlix公司 样品收集、保持和测定
US11280706B2 (en) 2017-08-01 2022-03-22 Essenlix Corporation Dilution calibration
CN112689758A (zh) 2017-08-01 2021-04-20 Essenlix公司 检查药物对微生物影响的装置和方法
US11393561B2 (en) 2017-10-13 2022-07-19 Essenlix Corporation Devices and methods for authenticating a medical test and use of the same
US10807095B2 (en) 2017-10-26 2020-10-20 Essenlix Corporation Making and tracking assay card
US11609224B2 (en) 2017-10-26 2023-03-21 Essenlix Corporation Devices and methods for white blood cell analyses
US11237113B2 (en) 2017-10-26 2022-02-01 Essenlix Corporation Rapid pH measurement
WO2019118652A1 (en) 2017-12-12 2019-06-20 Essenlix Corporation Sample manipulation and assay with rapid temperature change
CN112534259A (zh) 2017-12-14 2021-03-19 Essenlix公司 监测毛发的装置，***和方法
US11156606B2 (en) 2018-01-11 2021-10-26 Essenlix Corporation Homogeneous assay (II)
US11885952B2 (en) 2018-07-30 2024-01-30 Essenlix Corporation Optics, device, and system for assaying and imaging

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133866A (en) 1988-03-24 1992-07-28 Terrapin Technologies, Inc. Method to identify analyte-bending ligands
US5010175A (en) 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
WO1991005262A1 (en) 1989-10-02 1991-04-18 University Of Michigan Bioanalytical detection system
US5498538A (en) 1990-02-15 1996-03-12 The University Of North Carolina At Chapel Hill Totally synthetic affinity reagents
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
DE69228701T2 (de) 1991-12-03 1999-07-29 Proteus Molecular Design Ltd., Macclesfield, Cheshire Fragmente von Prion Proteinen.
US5312730A (en) 1992-05-27 1994-05-17 Ciba Corning Diagnostics Corp. Immune complex transfer with lypophilic bridge
JPH08178926A (ja) 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
US5834318A (en) 1995-05-10 1998-11-10 Bayer Corporation Screening of combinatorial peptide libraries for selection of peptide ligand useful in affinity purification of target proteins
US5750361A (en) 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
DE69724619T2 (de) * 1996-05-14 2004-07-01 Winnacker, Ernst-Ludwig, Prof. Chaperone, die prionproteine binden und zwischen den isoformen prpc und prpsc unterscheiden können
US5808011A (en) 1996-07-01 1998-09-15 Biopure Corporation Method for chromatographic removal of prions
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US6750025B1 (en) * 1998-07-09 2004-06-15 V.I. Technologies, Inc. Method of detecting and isolating prion protein and variants thereof
US6437102B1 (en) * 1999-11-24 2002-08-20 Bayer Corporation Method of separating prions from biological materials
EP1272509A2 (en) * 2000-04-05 2003-01-08 V.I. Technologies, Inc. Prion-binding peptidic ligands and methods of using same
IES20010042A2 (en) * 2001-01-19 2002-12-11 Enfer Technology Ltd Test for transmissible spongiform encephalopathies
DE10107083C2 (de) * 2001-02-13 2003-02-20 Abdulgabar Salama Pentosan Polysulfat als Ligand zum Nachweis von Prionen
US7022486B2 (en) 2001-08-13 2006-04-04 Douglas A. Campbell Peptide sequence tags and method of using same
DE10152677A1 (de) 2001-10-19 2003-05-08 Aventis Behring Gmbh Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführten Nachweisverfahren

Also Published As

Publication number Publication date
US20050014196A1 (en) 2005-01-20
WO2004090102A2 (en) 2004-10-21
HK1091894A1 (en) 2007-01-26
EP1615992A4 (en) 2007-11-07
PT1615992E (pt) 2013-11-29
ES2436638T3 (es) 2014-01-03
NZ543371A (en) 2008-04-30
US7393658B2 (en) 2008-07-01
CN1842707B (zh) 2012-06-27
EP1615992A2 (en) 2006-01-18
WO2004090102A3 (en) 2006-03-16
EG26681A (en) 2014-06-01
AU2004227389A1 (en) 2004-10-21
IL171279A (en) 2014-01-30
AU2004227389B2 (en) 2010-09-16
CN1842707A (zh) 2006-10-04
SG187269A1 (en) 2013-02-28
JP4783727B2 (ja) 2011-09-28
EP1615992B1 (en) 2013-08-28
PL1615992T3 (pl) 2014-03-31
JP2006522344A (ja) 2006-09-28
CA2521438C (en) 2014-03-25
CA2521438A1 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
DK1615992T3 (da) Prionproteinbindende materialer og fremgangsmåder til anvendelse
TNSN07136A1 (en) Prion protein binding materials and methods of use
DK1953551T3 (da) Prion-proteinligander samt fremgangsmåder til anvendelse deraf
UA96421C2 (ru) Нуклеотидная последовательность, кодирующая инсектицидный белок
ATE478342T1 (de) Kompakte vorrichtung, zusammensetzungen und verfahren zur reinigung von nukleinsäuren
DK2314623T3 (da) Il-1 beta-bindende antistoffer og fragmenter deraf
DE602004022922D1 (de) Peptide fähig die Dimerisierung von c-Jun zu inhibieren
EP1915390A4 (en) COMPOSITIONS AND METHODS FOR MONITORING AND MODIFYING PROTEIN FOLDING AND SOLUBILITY
DK2046951T3 (da) Proteasesreeningsmetoder og proteaser identificeret dermed
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
DE602006018424D1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
DK1536778T3 (da) Proteiner, der binder til cross-beta-strukturholdigt amyloid og fremgangsmåder til modulation af cross-beta-strukturen, dens dannelse og dens associerede toksicitet
ATE446314T1 (de) Methode zur reinigung von fsh
ATE533055T1 (de) Verfahren zum screenen mithilfe von konformationsempfindlichen peptiden
DK1604209T3 (da) Screeningsassay
WO2007100807A3 (en) Npc1l1 orthologues
DE60218848D1 (de) Verfahren zur trennung und/oder zum nachweis und/oder zur identifizierung und/oder zur quantifizierung von prionproteinen
ATE426046T1 (de) Stoffliche nutzung von biogas
CY1115280T1 (el) Μεθοδος ρυθμισης εκφρασης γονιδιου
WO2006044551A3 (en) Methods to differentiate protein conformers
WO2009045596A3 (en) Optimized dengue virus entry inhibitory peptide (10an)
DE502006006113D1 (de) Selektion von phosphatase kodierenden nukleinsäuremolekülen
ATE426817T1 (de) Verfahren zur identifizierung von proteinfaltungsinhibitoren